SLN.L - Silence Therapeutics plc

LSE - LSE Delayed price. Currency in GBp
Currency in GBp

Valuation measures

Market cap (intra-day) 5387.46M
Enterprise value 3255.96M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)1,587.93
Price/book (mrq)1,752.67
Enterprise value/revenue 31,049.01
Enterprise value/EBITDA 6-11.45

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3639.84%
S&P500 52-week change 35.46%
52-week high 3646.50
52-week low 342.00
50-day moving average 3421.67
200-day moving average 3423.60

Share statistics

Avg vol (3-month) 3213.43k
Avg vol (10-day) 3113.01k
Shares outstanding 582.8M
Float 38.1M
% held by insiders 168.07%
% held by institutions 118.17%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 330 Apr 2013

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)31 Dec 2019

Profitability

Profit margin 0.00%
Operating margin (ttm)-9,317.21%

Management effectiveness

Return on assets (ttm)-33.45%
Return on equity (ttm)-69.98%

Income statement

Revenue (ttm)244k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-13.09M
EBITDA -22.35M
Net income avi to common (ttm)-19.58M
Diluted EPS (ttm)-26.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33.52M
Total cash per share (mrq)0.43
Total debt (mrq)287k
Total debt/equity (mrq)1.37
Current ratio (mrq)3.88
Book value per share (mrq)0.27

Cash flow statement

Operating cash flow (ttm)1.73M
Levered free cash flow (ttm)-8.62M
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more